The effect of nifedipine and indomethacin on pregnant wome

Phase 3

Recruiting

Conditions: Condition 1: Differences in the number of white blood cells. Condition 2: Elevated C-reactive protein (CRP).
Other disorders of white blood cells
Elevated C-reactive protein (CRP)
R79.82

Registration Number: IRCT20220219054064N1

Lead Sponsor: Yasouj University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Recruiting

Sex: Female

Target Recruitment: 64

Inclusion Criteria

26-34 weeks gestational age confirmed by NLO and first trimester ultrasound
Contractions of four numbers in 20 minutes or eight in 60 minutes
Cervical dilatation equal to or more than 1 cm and cervical effusion 50% or more

Exclusion Criteria

Inflammatory diseases, autoimmune, infectious, multiple, hypertension, diabetes, cervical insufficiency, bladder rupture, vaginal bleeding, fetal death or fetal malignancy, KWFT, history of trauma, cirrhosis, dilatation, cirrhosis Maternal, known uterine abnormalities (with a history or ultrasound), smoking history, history of taking any medication other than the usual supplements during pregnancy, tuberculosis, intrauterine polycystic ovary syndrome, ulcerative colitis Maternal and fetal HJT, previous tocolytic use in the same pregnancy and mothers for whom continuing pregnancy for medical reasons is dangerous and blood pressure less than 50.90 mm Hg

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Reactive Protein Test. Timepoint: The measurement is performed on the first day after delivery. Method of measurement: Blood test and use of photometric analyzer.;Number of uterine contractions. Timepoint: In the first 2 hours after administration of the drug, it will be checked every 15 minutes and if controlled, every 4-6 hours. Method of measurement: See the number of contractions.;Number of white blood cells. Timepoint: The first day after delivery. Method of measurement: CBC DIFF.

Secondary Outcome Measures